Stockreport

Structure Therapeutics Inc. (GPCR) Discusses Positive Topline Results from ACCESS II and Related Studies of Aleniglipron Oral GLP-1 Transcript [Seeking Alpha]

Structure Therapeutics Inc.  (GPCR) 
PDF Company Participants Raymond Stevens - CEO & Director Blai Coll - Chief Medical Officer Conference Call Participants Corey Davis - Lifesci Advisors, LLC Yasme [Read more]